GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » Shandong Bailong Chuangyuan Bio-Tech Co Ltd (SHSE:605016) » Definitions » Equity-to-Asset

Shandong Bailong Chuangyuan Bio-Tech Co (SHSE:605016) Equity-to-Asset : 0.83 (As of Mar. 2024)


View and export this data going back to 2021. Start your Free Trial

What is Shandong Bailong Chuangyuan Bio-Tech Co Equity-to-Asset?

Equity to Asset ratio is calculated as total stockholders equity divided by total asset. Shandong Bailong Chuangyuan Bio-Tech Co's Total Stockholders Equity for the quarter that ended in Mar. 2024 was ¥1,561.4 Mil. Shandong Bailong Chuangyuan Bio-Tech Co's Total Assets for the quarter that ended in Mar. 2024 was ¥1,886.3 Mil. Therefore, Shandong Bailong Chuangyuan Bio-Tech Co's Equity to Asset Ratio for the quarter that ended in Mar. 2024 was 0.83.

The historical rank and industry rank for Shandong Bailong Chuangyuan Bio-Tech Co's Equity-to-Asset or its related term are showing as below:

SHSE:605016' s Equity-to-Asset Range Over the Past 10 Years
Min: 0.57   Med: 0.87   Max: 0.94
Current: 0.83

During the past 8 years, the highest Equity to Asset Ratio of Shandong Bailong Chuangyuan Bio-Tech Co was 0.94. The lowest was 0.57. And the median was 0.87.

SHSE:605016's Equity-to-Asset is ranked better than
89.29% of 1933 companies
in the Consumer Packaged Goods industry
Industry Median: 0.54 vs SHSE:605016: 0.83

Shandong Bailong Chuangyuan Bio-Tech Co Equity-to-Asset Historical Data

The historical data trend for Shandong Bailong Chuangyuan Bio-Tech Co's Equity-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shandong Bailong Chuangyuan Bio-Tech Co Equity-to-Asset Chart

Shandong Bailong Chuangyuan Bio-Tech Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Equity-to-Asset
Get a 7-Day Free Trial 0.79 0.83 0.94 0.91 0.86

Shandong Bailong Chuangyuan Bio-Tech Co Quarterly Data
Dec18 Jun19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Equity-to-Asset Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.90 0.88 0.88 0.86 0.83

Competitive Comparison of Shandong Bailong Chuangyuan Bio-Tech Co's Equity-to-Asset

For the Packaged Foods subindustry, Shandong Bailong Chuangyuan Bio-Tech Co's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Shandong Bailong Chuangyuan Bio-Tech Co's Equity-to-Asset Distribution in the Consumer Packaged Goods Industry

For the Consumer Packaged Goods industry and Consumer Defensive sector, Shandong Bailong Chuangyuan Bio-Tech Co's Equity-to-Asset distribution charts can be found below:

* The bar in red indicates where Shandong Bailong Chuangyuan Bio-Tech Co's Equity-to-Asset falls into.



Shandong Bailong Chuangyuan Bio-Tech Co Equity-to-Asset Calculation

Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.

Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.

Shandong Bailong Chuangyuan Bio-Tech Co's Equity to Asset Ratio for the fiscal year that ended in Dec. 2023 is calculated as

Equity to Asset (A: Dec. 2023 )=Total Stockholders Equity/Total Assets
=1507.828/1754.18
=0.86

Shandong Bailong Chuangyuan Bio-Tech Co's Equity to Asset Ratio for the quarter that ended in Mar. 2024 is calculated as

Equity to Asset (Q: Mar. 2024 )=Total Stockholders Equity/Total Assets
=1561.371/1886.31
=0.83

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Shandong Bailong Chuangyuan Bio-Tech Co  (SHSE:605016) Equity-to-Asset Explanation

Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.

For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.


Shandong Bailong Chuangyuan Bio-Tech Co Equity-to-Asset Related Terms

Thank you for viewing the detailed overview of Shandong Bailong Chuangyuan Bio-Tech Co's Equity-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.


Shandong Bailong Chuangyuan Bio-Tech Co (SHSE:605016) Business Description

Traded in Other Exchanges
N/A
Address
Dexin Street, National High-tech Industrial Development Zone, Yucheng, Shandong Province, Dezhou, CHN, 251200
Shandong Bailong Chuangyuan Bio-Tech Co Ltd is engaged in the research and development, production and sales of prebiotic series products, dietary fiber series products, other starch sugar (alcohol) series products and healthy sweetener products.
Executives
Zhang An Guo Director

Shandong Bailong Chuangyuan Bio-Tech Co (SHSE:605016) Headlines

No Headlines